| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-10 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |